5-FU: |
5-fluorouracil |
CEA: |
carcinoembryonic antigen |
CLM: |
colorectal liver metastases |
CONSORT: |
consolidated standards of reporting trials |
CR: |
complete response |
DFS: |
disease-free survival |
EGFR: |
epithelial growth factor receptor |
HR: |
hazard ratio |
HS-RFS: |
hepatic-specific relapse-free survival |
IQR: |
interquartile range |
IV: |
intravenous |
mAb: |
monoclonal antibody |
N: |
number |
NA: |
not available |
NC/SD: |
no change/stable disease |
NE: |
not evaluable |
OS: |
overall survival |
PD: |
progression of disease |
PO: |
per os |
PO-SACT: |
pre-operative systemic anticancer therapy |
PR: |
partial response |
RAS: |
rat sarcoma virus |
SD: |
standard deviation |
UK: |
unknown |
VEGF: |
vascular endothelial growth factor |
Y: |
yes |